CARFILZOMIB
carfilzomib 10 mg injection, 1 vial
CARFILZOMIB (13637R)
13637R
Manner of administration:Injection
Restriction (Streamlined authority code: 14389)
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment for Cycles 1 to 3
Restriction (Streamlined authority code: 14363)
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment for Cycles 3 to 12
Restriction (Streamlined authority code: 14364)
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment for Cycles 13 onwards
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 60 mg | # of repeats: 17 | DPMA: $1,359.27 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Kyprolis
(carfilzomib 10 mg injection, 1 vial)
|
||||
| Kyprolis
(carfilzomib 30 mg injection, 1 vial)
|
||||
| Kyprolis
(carfilzomib 60 mg injection, 1 vial)
|
||||